Skip to main content

CLOVER HEALTH INVESTMENTS CORP DE

For the period ended Dec 31, 2023. Filed Mar 14, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 14, 2024

CLOV$4.93+2.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 15. Exhibits and Financial Statement Schedules

(a) The Financial Statements, Financial Statement Schedules, and exhibits set forth below are filed as part of this Form 10-K.

(1) Financial Statements-The response to this portion of Item 15 is submitted as Item 8 of Part II of this Form 10-K.

(2) Financial Statement Schedules-The response to this portion of Item 15 is submitted as Item 8 of Part II of this Form 10-K.

(3) A list of exhibits to this Form 10-K is set forth below:

Incorporated by reference
ExhibitNo. · Description · Form · File No. · Exhibit No. · Filing date · Filed or furnished herewith
2.1*Agreement and Plan of Merger, dated as of October 5, 2020, by and among the Registrant, Asclepius Merger Sub Inc. and Clover Health Investments, Corp.8-K001-392522.110/6/2020
2.1(a)Amendment to the Agreement and Plan of Merger, dated as of December 8, 20208-K001-392522.112/10/2020
3.1Amended and Restated Certificate of Incorporation of the Registrant8-K001-392523.11/12/2021
3.2Amended and Restated Bylaws of the Registrant8-K001-392523.21/12/2021
4.1Specimen Class A Common Stock Certificate of the RegistrantS-4/A333-2495584.511/20/2020
4.2Specimen Class B Common Stock Certificate of the RegistrantS-4/A333-2495584.611/20/2020
4.3Description of Securities10-K001-392524.302/28/2022
10.1*Form of Indemnification Agreement8-K001-3925210.21/12/2021
10.2*Amended and Restated 2014 Equity Incentive Plan, and forms of agreement thereunderS-4333-24955810.1510/20/2020
10.3*2020 Equity Incentive Plan and forms of agreement thereunder8-K001-3925210.41/12/2021
10.4*2020 Employee Stock Purchase Plan8-K001-3925210.51/12/2021
10.5*Management Incentive Plan8-K001-3925210.61/12/2021
10.6*Executive Incentive Bonus Plan8-K001-3925210.71/12/2021
10.7*Employment Agreement, effective as of December 31, 2021, between the Registrant and Jamie L. Reynoso10-K001-3925210.1202/28/2022
10.8*Employment Agreement, effective as of March 14, 2022, between the Registrant and Joseph Martin10-Q001-3925210.105/09/2022
10.9*Employment Agreement, dated as of May 11, 2022, between the Registrant and Scott J. Leffler10-Q001-3925210.108/08/2022
10.10*Employment Agreement, effective as of May 9, 2022, between the Registrant and Aric Sharp10-Q001-3925210.208/08/2022
10.11*Employment Agreement, dated as of July 18, 2022, between the Registrant and Brady Priest10-K001-3925210.1403/01/2023
10.12*Employment Agreement, dated as of August 8, 2022, between the Registrant and Andrew Toy10-Q001-3925210.111/07/2022
10.13*Amended and Restated Director Compensation Policy10-Q001-3925210.211/07/2022
10.14*Board Observer Agreement, dated as of March 16, 2023, between the Registrant and Zach Weinberg.8-K001-3952510.103/17/2023
10.15*Employment Agreement, dated as of February 24, 2022, between the Registrant and Conrad Wai10-Q001-3925210.205/09/2023
10.16*Employment Agreement, dated as of March 8, 2024, between the Registrant and Karen Soares.X
10.17*Agreement for the Provision of Interim Management Service, dated as of December 22, 2023 between the Registrant and AP Services, LLC.X
21.1List of SubsidiariesX
23.1Consent of Independent Registered Public Accounting FirmX
31.1Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002X
31.2Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002X
32.1†Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002X
32.2†Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002X
97.1Clover Health Investments, Corp. Clawback PolicyX
101.INSInline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema Document
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
101.LABInline XBRL Taxonomy Extension Label Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (embedded within the Inline XBRL document)

† Furnished herewith.

  • Indicates a management contract or compensatory plan or arrangement.

** Schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). The registrant hereby agrees to furnish supplementary a copy of any omitted schedule to the SEC upon its request.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.